RSS   Newsletter   Contact   Advertise with us
Post Online Media

Rexahn Pharma appoints Lisa Nolan as chief business officer

RexahnRexahn Pharmaceuticals, a clinical stage pharmaceutical company, announced the appointment of Lisa Nolan to the newly-created position of chief business officer.
Article continues below

READ MORE Rexahn appoints Richard Rodgers to board of directors

Dr. Nolan joins Rexahn from Relmada Therapeutics where she held the position of Chief Business Officer. Prior to this, she was Managing Director of Nolex Advisors where she led competitive processes for out-licensing of early and late-stage pharmaceutical products.

Over the course of her career, Dr. Nolan has held various leadership roles at biopharmaceutical companies including Chief Business Officer at Topigen Pharmaceuticals, where she championed and led the acquisition of Topigen by Pharmaxis.

Additionally, she served as Vice President, Global Business Development and Strategic Marketing for SkyePharma.

She holds a Ph.D. in clinical pharmacology and a M.Sc. and B.Sc. in pharmacy from Trinity College in Dublin, Ireland.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy